Literature DB >> 2389310

Incidence of localized cutaneous leishmaniasis (chiclero's ulcer) in Mexico.

F J Andrade-Narváez1, E Simmonds-Díaz, S Rico-Aguilar, M Andrade-Narvéez, A Palomo-Cetina, S B Canto-Lara, M R García-Miss, M Madera-Sevilla, N Albertos-Alpuche.   

Abstract

Cutaneous leishmaniasis in Mexico was first described in 1912. Since then, its existence has been repeatedly confirmed in the forest regions of the peninsula of Yucatan. In order to obtain reliable knowledge about the magnitude of this problem, we questioned and skin-tested a sample of 449 persons randomly selected from men aged 15-45 years. We found a positivity rate of 24 to 90% (mean 43%) in the seven rural health posts studied. Furthermore, 72 patients were examined between January and December 1987 by parasitological investigation (smear, isolation, culture and/or biopsy) and the Montenegro skin test; 56 had acquired the disease in 1987. Based on these data, we found an annual incidence rate of 508 per 100,000 inhabitants. Further long-term studies are indicated to determine the incidence and prevalence rates for this disease in other parts of the country.

Entities:  

Mesh:

Year:  1990        PMID: 2389310     DOI: 10.1016/0035-9203(90)90262-d

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice.

Authors:  Fabiola Aguilar Torrentera; Jon D Laman; Marjan Van Meurs; Luciano Adorini; Eric Muraille; Y Carlier
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis.

Authors:  P C Melby; F J Andrade-Narvaez; B J Darnell; G Valencia-Pacheco; V V Tryon; A Palomo-Cetina
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

3.  Nitric oxide production by Peromyscus yucatanicus (Rodentia) infected with Leishmania (Leishmania) mexicana.

Authors:  Elsy Nalleli Loría-Cervera; Erika Ivett Sosa-Bibiano; Liliana Estefanía Villanueva-Lizama; Nicole Raymonde Van Wynsberghe; Silvia Beatriz Canto-Lara; José Luis Batún-Cutz; Fernando José Andrade-Narváez
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

4.  Antileishmanial activity of a mixture of Tridax procumbens and Allium sativum in mice.

Authors:  Rubi Gamboa-Leon; Marina Vera-Ku; Sergio R Peraza-Sanchez; Carlos Ku-Chulim; Aurelio Horta-Baas; Miguel Rosado-Vallado
Journal:  Parasite       Date:  2014-04-10       Impact factor: 3.000

Review 5.  Leishmaniasis: a review.

Authors:  Edoardo Torres-Guerrero; Marco Romano Quintanilla-Cedillo; Julieta Ruiz-Esmenjaud; Roberto Arenas
Journal:  F1000Res       Date:  2017-05-26

6.  ITS1 PCR-RFLP Diagnosis and Characterization of Leishmania in Clinical Samples and Strains from Cases of Human Cutaneous Leishmaniasis in States of the Mexican Southeast.

Authors:  Amalia Monroy-Ostria; Abedelmajeed Nasereddin; Victor M Monteon; Carmen Guzmán-Bracho; Charles L Jaffe
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-07-01

7.  Preliminary epidemiological findings of Leishmania infection in the municipality of Tinum, Yucatan State, Mexico.

Authors:  Elsy Nalleli Loría-Cervera; Erika Ivett Sosa-Bibiano; Nicole R Van Wynsberghe; Jimmy Raymundo Torres-Castro; Fernando José Andrade-Narváez
Journal:  Parasite Epidemiol Control       Date:  2019-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.